
Former NCPA President Presses for PBM Reform in Congressional Hearing

Key Takeaways
- Hugh Chancy emphasized the need for PBM reforms to maintain fair competition and healthcare access.
- Proposed reforms target transparency, spread pricing in Medicaid, and fair contract terms in Medicare Part D.
Anticompetitive PBM tactics lead to higher costs, limited choices, and pharmacy deserts.
ALEXANDRIA, Va. (Feb. 26, 2025) – Hugh Chancy, former president of the National Community Pharmacists Association and a co-owner of Chancy Drugs in South Georgia, implored members of Congress to take immediate action and pass common-sense pharmacy benefit manager reforms while serving as a witness in
“We are not asking for favorable treatment, but merely a level playing field,” said Chancy’s statement for the record. “I encourage lawmakers on both sides to continue to work in a bipartisan manner to pass these reforms that save $5 billion. If not, we will see more pharmacy deserts and less access to care.”
NCPA is
To read Chancy’s statement,
To read NCPA’s statement,
Additionally, as part of its multi-pronged approach to push for PBM reform to be passed as soon as possible, NCPA partnered with the Coalition of State Rheumatology Organizations, the ERISA Industry Committee, Blue Shield of California, the Diabetes Patient Advocacy Coalition, TransparencyRx, the National Grange, the American Free Enterprise Chamber of Commerce, and the National Association of Chain Drug Stores and held a Feb. 25 briefing on Capitol Hill for members of Congress and their staff to learn more about this critical issue. Speakers included Reps. James Comer (R-Ky.), Debbie Dingell (D-Mich.) and Jake Auchincloss (D-Mass.) as well as Ohio Attorney General Dave Yost.
Founded in 1898, the National Community Pharmacists Association is the voice for the community pharmacist, representing over 18,900 pharmacies that employ more than 205,000 individuals nationwide. Community pharmacies are rooted in the communities where they are located and are among America’s most accessible health care providers. To learn more, visit
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.